Q3 results, new Group CRO, Rs 100 cr NAML investment, strategy review
NUVAMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.7 pts less than Nifty Smallcap 250 and 5.4 pts less than its Stockbroking & Allied peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Board approved Q3 FY26 results: standalone net profit Rs 280.29 cr vs Rs 206.86 cr YoY, 9M net profit Rs 548.12 cr. Consolidated 9M PAT Rs 771.47 cr. Mr Keyur Ajmera appointed Group CRO from Feb 1, 2026, replacing Mr Ananthakrishnan who moves to a new group role. Investment of up to Rs 100 cr in wholly owned subsidiary Nuvama Asset Management. Board also evaluating strategies for shareholder value discovery, including possible business segment reorganization.
Strong Q3 results lifted by dividend income. Smooth CRO transition and subsidiary investment signal growth focus. Strategic review may unlock value.